Monday, August 05, 2024 9:27:08 AM
I don't want to hear about what a great guy Shawn Leon it frankly. To know the nature of the people that you are dealing with look back to the Leonite share dump of February 28th 2022. February 27th Ethema Health announces a series of press releases to come. Twitter followers showed up the next morning to the tune of 200 million shares traded in the first 30 minutes running it up just over .001 where Leonite hammered it with the new shares. Four press releases and 654 million shares for the week and by the following Friday it was trading right back where it started. It was a pretty good tactic and shows what happens when a company and toxic lender collaborate. This was the last time that they have been able to convert debt for the common stock. Now even with all this fan fare they are having difficulty attracting any volume to support the offerring.
Even thou you claim you don't own shares and love shareholders, we love our ceo Leon, he has the qualities and skills to lead and compassion to run addiction centers. CEO's are entitled to pay!
Re: janetcanada post# 50744
Wednesday, July 31, 2024 10:48:11 AM
Post# 50749 of 50826
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174841515&txt2find=management%2Bfees
Filings going back years state that management fees were forfeited. The language is pretty unambiguous concerning this subject in the filings. Looks to me like he is trying to take the $420K as part of the conversions to acquire more than a 52% stake in this to take the sting out of it. They must believe that they need controlling interest to work the plan. That plan is in the interest of those who held more than $7 million in what Shawn Leon calls "friendly debt".
Coming this week, updates on financial results, audit, debt reduction, expansion plans, and real estate. $GRST
— Ethema Health (@HealthEthema) February 27, 2022
For the quarterly period ended March 31, 2022
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0000792935/000190359622000301/sfsgrst10q051122.htm
10. Short-term Convertible Notes (continued)
Leonite Capital, LLC (continued)
On February 28, 2022, in terms of a conversion notice, Leonite converted the principal sum of $149,250 of the Leonite Note into 150,000,000 shares of common stock at a conversion price of $0.0010 per share.
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent GRST News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/13/2026 06:50:44 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:17:00 PM
- DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event • ACCESS Newswire • 01/23/2026 07:50:00 PM
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 12/10/2025 02:57:30 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/05/2025 01:35:00 PM
- Ethema Health to Present at the Small Cap Growth Virtual Investor Conference December 9th • GlobeNewswire Inc. • 12/04/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/03/2025 10:21:56 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 05:27:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2025 10:25:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/17/2025 05:21:14 PM
